Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Medtronic
Boehringer Ingelheim
Dow
Johnson and Johnson

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Misonidazole

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Misonidazole: Patents, clinical trial progress, indications

Misonidazole is an investigational drug.

There have been 13 clinical trials for Misonidazole. The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2007.

The most common disease conditions in clinical trials are Glioblastoma, Lung Neoplasms, and Carcinoma, Non-Small-Cell Lung. The leading clinical trial sponsors are National Cancer Institute (NCI), Proacta, Incorporated, and AstraZeneca.

Recent Clinical Trials for Misonidazole
TitleSponsorPhase
Feasibility of FMISO in Brain TumorsNational Cancer Institute (NCI)Phase 2
Feasibility of FMISO in Brain TumorsOHSU Knight Cancer InstitutePhase 2
Pilot Study of 18F-FMISO PET/CT and MRI Imaging to Explore Tissue Hypoxia and Arteriovenous Shunting in Subjects With Recurrent Glioblastoma Before and After Bevacizumab TreatmentAbramson Cancer Center of the University of PennsylvaniaPhase 1

See all Misonidazole clinical trials

Clinical Trial Summary for Misonidazole

Top disease conditions for Misonidazole
Top clinical trial sponsors for Misonidazole

See all Misonidazole clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
McKesson
Merck
Moodys
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.